HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

FDA Clears Clarius AI for Real-Time Cardiac Ultrasound

Created at 2 Jun · 12:44 PM2 sources↑ Market-relevant2 events
IN SHORT

The FDA has cleared Clarius Mobile Health's AI tool, integrated into the Clarius App, for automated Left Ventricular Ejection Fraction (LVEF) calculations. This aims to accelerate diagnosis and remove subjectivity in cardiac ultrasound assessments at the point of care.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Who's Involved

FDA
U.S. regulatory body that cleared the AI tool
Clarius Mobile Health
Developer of the AI tool and ultrasound systems

↳ Why This Matters

This FDA clearance signifies a step forward in leveraging AI to improve the speed and objectivity of cardiac diagnostics, potentially leading to earlier interventions and better patient outcomes.

Key facts

  • FDA cleared Clarius Mobile Health's AI tool for cardiac ultrasound.
  • The AI tool automates Left Ventricular Ejection Fraction (LVEF) calculation.
  • LVEF is a key indicator of heart pumping efficiency.
  • The tool is integrated into the Clarius App.
  • It aims to remove subjectivity and accelerate diagnosis at the point of care.

Clarius Mobile Health has received FDA clearance for its new AI tool, designed to enhance cardiac ultrasound assessments. Integrated into the Clarius App, this tool automates the calculation of Left Ventricular Ejection Fraction (LVEF), a critical measure of heart function. By providing objective, real-time data, the AI aims to improve diagnostic speed and accuracy, particularly in primary care and emergency medicine settings where rapid assessment is crucial.

Frequently asked questions

It automates the calculation of Left Ventricular Ejection Fraction (LVEF), a measure of heart pumping efficiency, using cardiac ultrasound data.

LVEF is a key indicator of how well the heart is pumping blood, representing the percentage of blood that is pumped out of the left ventricle with each contraction.

The tool is intended for use in primary care and emergency medicine settings, leveraging ultrasound at the point of care.

What Happens Next

01Clarius Mobile Health will likely focus on broader market adoption and integration into clinical workflows.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

2 Jun · 3:06 PM
Mindray launches expanded Hepatus-Series ultrasound systems for gastroenterology imaging, integrating ultrasound and elastography.
PRN | All News Releases via PiQSuite
2 Jun · 12:32 PM
The FDA has cleared Clarius's new AI tool, integrated into their app, to automate LVEF calculation for real-time cardiac ultrasound assessments.
PRN | All News Releases via PiQSuite

Sources

T1
FDA Clears Clarius Ejection Fraction AI to Deliver Objective, Real-Time Cardiac Ultrasound Assessments for Primary Care and Emergency Medicinem.piqsuite.com
T1
Mindray Leads the Evolution of Gastroenterology Imaging with the Newly Expanded Hepatus-Series Ultrasound Systemsm.piqsuite.com

Related Stories

OpenAI launches GPT-Live voice models for simultaneous listening and speaking
8 Jul · 5:56 PM
Cerebras Plans Major European AI Expansion, Challenges Nvidia
9 Jul · 9:56 AM
City Labs launches world's first commercial nuclear-powered satellite
8 Jul · 5:30 PM
Google revamps Android AI dev benchmark, adds Fable 5 and other agents
8 Jul · 4:45 PM
Startup General Intuition aims for robotics' 'ChatGPT moment' with foundation models
8 Jul · 7:40 PM